Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
46.35    1.10 (2.43%)
Bid:
46.35
Ask:
46.65
Spread: 0.30 (0.647%)
Market Cap: £293.33m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

30 Jun 2008 15:31

RNS Number : 9031X
Marston's PLC
30 June 2008
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND CONNECTED PERSONS

1.

Name of the issuer:

Marston's PLC

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4 (R) (1) (a) or (ii) DR 3.1.4 (R) (1) (b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985 or (iii) both (i) and (ii):

both

3.

Name of person discharging managerial responsibilities/director:

Paul Inglett

Ralph Findlay

Derek Andrew

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director names in 3 and identify the connected person:

Persons named in 3

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:

Persons named in 3

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares:

Ordinary shares of 7.375p each

7.

Name of registered shareholder(s) and, if more than one, the number of shares held by each of them:

8.

State the nature of the transaction:

Grant of SAYE option

9.

Number of shares, debentures or financial instruments relating to shares acquired:

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage):

11.

Number of shares, debentures or financial instruments relating to shares disposed:

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage):

13.

Price per share or value of transaction:

14.

Date and place of transaction:

15.

Total holding following notification and total percentage holding following notification (any treasury shares of that class should not be taken into account when calculating percentage):

16.

Date issuer informed of transaction:

17.

Date of grant:

30 June 2008

18.

Period during which or date on which it can be exercised:

Paul Inglett - 1 September 2011

Ralph Findlay - 1 September 2013

Derek Andrew - 1 September 2015

19.

Total amount paid (if any) for grant of the option:

Nil

20.

Description of shares or debentures involved (class and number):

Ordinary 9,462

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise:

172p

22.

Total number of shares or debentures over which options held following notification:

Paul Inglett - SAYE 9,251

Ralph Findlay - SAYE 17,330

Derek Andrew - SAYE 18,623

23.

Any additional information:

24.

Name of contact and telephone for queries:

Anne-Marie Brennan, 01902 329506

Name and signature of duly authorised officer of issuer responsible for making notification.

……………………………………

Anne-Marie Brennan

Company Secretary

Date of notification: 13/06/08

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEALKEDAPPEFE
Date   Source Headline
8th Jun 202011:48 amRNSPublication of Circular and Notice of GM
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
29th May 202010:47 amRNSCOVID-19 Update Results Noteholder Consent Request
22nd May 20204:35 pmRNSPrice Monitoring Extension
22nd May 20201:35 pmRNSMarston’s and Carlsberg UK form JV Partnership
14th May 20207:00 amRNSCOVID-19 Financing and Dividend Update
7th May 202012:57 pmRNSCOVID-19 Update re: Noteholder Consent Request
4th May 202012:12 pmRNSChange to Interim Results Announcement Date
20th Apr 20207:00 amRNSCOVID-19 Update re: securitisation waiver granted
18th Mar 20207:00 amRNSCOVID-19 Update
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Feb 202012:51 pmRNSTotal Voting Rights
27th Jan 202010:19 amRNSResult of AGM
24th Jan 20207:00 amRNSTrading Update
10th Jan 20209:20 amRNSBlock listing Interim Review
2nd Jan 202011:43 amRNSTotal Voting Rights
27th Dec 20197:00 amRNSDirector Declaration
18th Dec 20194:28 pmRNSAnnual Financial Report
12th Dec 20193:52 pmRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSPreliminary Results
25th Nov 20197:00 amRNSCompletion of Disposal
21st Nov 20192:52 pmRNSDirectorate Change
4th Nov 20197:00 amRNSDisposal
1st Nov 20192:24 pmRNSTotal Voting Rights
15th Oct 20197:00 amRNSYear End Trading Update
1st Oct 201910:05 amRNSTotal Voting Rights
2nd Sep 20192:15 pmRNSTotal Voting Rights
29th Jul 20197:00 amRNSBoard Changes
24th Jul 20197:00 amRNSTrading Update
10th Jul 201911:15 amRNSBlock listing Interim Review
17th Jun 20193:37 pmRNSDirector/PDMR Shareholding
15th May 20197:00 amRNSInterim results for 26 weeks ended 30 March 2019
4th Mar 201911:51 amRNSTotal Voting Rights
1st Feb 20199:11 amRNSTotal Voting Rights
24th Jan 201910:29 amRNSResult of AGM
23rd Jan 20197:00 amRNSTrading Update for the 16 weeks to 19 January 2019
11th Jan 20198:48 amRNSBlock listing Interim Review
2nd Jan 20192:20 pmRNSTotal Voting Rights
19th Dec 201811:04 amRNSAnnual Financial Report
13th Dec 20183:09 pmRNSDirector/PDMR Shareholding
13th Dec 20183:07 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSPreliminary Results
8th Nov 20188:46 amRNSHolding(s) in Company
6th Nov 20184:19 pmRNSHolding(s) in Company
2nd Nov 20182:39 pmRNSHolding(s) in Company
1st Nov 20183:35 pmRNSHolding(s) in Company
1st Nov 20181:25 pmRNSTotal Voting Rights
12th Oct 20184:07 pmRNSHolding(s) in Company
10th Oct 20187:00 amRNSYEAR END TRADING UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.